No Data
COFCO Technology: 2024 Annual Report Summary
COFCO Technology: Report for the first quarter of 2025
COFCO Technology: 2024 Annual Report
Cofco Biotechnology (000930.SZ): The net income in the first quarter was 40.5315 million yuan, a year-on-year increase of 63.17%.
Gelonghui reported on April 25 that Cofco Biotechnology (000930.SZ) announced its Q1 2025 report, achieving revenue of 4.385 billion yuan, a year-on-year decrease of 7.31%. The net income attributable to shareholders of the listed company was 40.5315 million yuan, an increase of 63.17% year-on-year. The net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was -10.5589 million yuan. The basic EPS was 0.0218 yuan.
Shareholders in COFCO Biotechnology (SZSE:000930) Have Lost 23%, as Stock Drops 5.1% This Past Week
Cofco Biotechnology (000930.SZ): No Beer hop fermentation operation project.
Gelonghui, April 15th丨Cofco Biotechnology (000930.SZ) stated on the interactive platform that the company does not have an Operation project for hop fermentation.
